Streetbeat News

CET

Central Securities Corp.

https://www.centralsecurities.com

Industry

Asset Management

Central Securities Corp. is a publicly owned investment manager. The firm invests in the public equity markets of the United States. It also invests on bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks and corporations. Central Securities Corp. was founded on October 1, 1929 and is based in New York, New York.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Insider trades were noted in three US-listed companies: Day One Biopharmaceuticals, Central Securities Corporation, and RE/MAX Holdings. Day One Biopharmaceuticals' 10% owner Len Blavatnik acquired 1,475,454 shares at an average price of $10.15, costing around $14.98 million. Central Securities Corporation's Vice President Andrew J. O'Neill acquired 1,954 shares at an average price of $35.80, costing around $69,947. RE/MAX Holdings' 10% owner Magnolia Group LLC bought 15,000 shares at an average price of $10.74, costing around $161,100.

Portfolio Pulse from Lisa Levin

October 23, 2023 | 10:44 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.